Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease
- Conditions
- Inflammatory bowel syndrome
- Registration Number
- JPRN-UMIN000052579
- Lead Sponsor
- Juntendo University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Not provided
The following patients are excluded from the standpoint of ensuring safety. 1. All cases with liver disease, renal disease, heart disease, or other serious complications that are judged inappropriate by the attending physician 2. Cases with other autoimmune diseases 3. All cases of lactating women, pregnant women or those who may be pregnant 4. Patients who are judged to be unsuitable by other doctors Among the above (1) research subjects, those who meet all (2) selection criteria and (3) none of the exclusion criteria are eligible.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency of local and systemic adverse events
- Secondary Outcome Measures
Name Time Method Effect of vaccination on primary disease of IBD